JIANZHIJIA PHARMACEUTICAL CHAIN GROUP CO., LTD. Financials Jianzhijia Pharmaceutical Chain Group Co., Ltd.
Equities
605266
CNE100004JG5
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.5 CNY | -1.25% |
|
+1.72% | -13.30% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,889 | 5,324 | 7,940 | 7,654 | 6,636 | - | - |
| Enterprise Value (EV) 1 | 5,889 | 5,324 | 7,940 | 7,654 | 6,636 | 6,636 | 6,636 |
| P/E ratio | 18.1 x | 17.6 x | 21.2 x | 18.4 x | 14.4 x | 11.1 x | 9.7 x |
| Yield | - | - | - | 2.16% | 2.5% | 3.05% | 3.73% |
| Capitalization / Revenue | 1.32 x | - | - | 0.84 x | 0.62 x | 0.48 x | 0.42 x |
| EV / Revenue | 1.32 x | - | - | 0.84 x | 0.62 x | 0.48 x | 0.42 x |
| EV / EBITDA | 16.3 x | - | - | 10.6 x | 6.82 x | 5.7 x | 4.77 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | 3.43 x | - | - | 2.68 x | 2.1 x | 1.86 x | 1.68 x |
| Nbr of stocks (in thousands) | 116,441 | 117,499 | 128,911 | 128,849 | 128,849 | - | - |
| Reference price 2 | 50.58 | 45.31 | 61.59 | 59.40 | 51.50 | 51.50 | 51.50 |
| Announcement Date | 4/14/21 | 4/27/22 | 4/26/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,466 | - | - | 9,081 | 10,768 | 13,920 | 15,719 |
| EBITDA 1 | 361 | - | - | 719.7 | 973.5 | 1,165 | 1,392 |
| EBIT 1 | 292.3 | - | - | 522.1 | 568.9 | 741.6 | 871.4 |
| Operating Margin | 6.54% | - | - | 5.75% | 5.28% | 5.33% | 5.54% |
| Earnings before Tax (EBT) 1 | 300.5 | - | - | 522.7 | 608.9 | 761.1 | 911.4 |
| Net income 1 | 251.1 | 300.5 | 363.4 | 414.4 | 460.2 | 601 | 684.7 |
| Net margin | 5.62% | - | - | 4.56% | 4.27% | 4.32% | 4.36% |
| EPS 2 | 2.799 | 2.580 | 2.900 | 3.220 | 3.570 | 4.660 | 5.310 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | 1.285 | 1.290 | 1.570 | 1.920 |
| Announcement Date | 4/14/21 | 4/27/22 | 4/26/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 31.8% | - | - | 15.2% | 14.6% | 16.8% | 17.3% |
| ROA (Net income/ Total Assets) | - | - | - | - | 6.26% | 6.68% | 7.06% |
| Assets 1 | - | - | - | - | 7,351 | 8,997 | 9,699 |
| Book Value Per Share 2 | 14.70 | - | - | 22.20 | 24.50 | 27.70 | 30.60 |
| Cash Flow per Share 2 | 2.720 | - | - | 7.950 | 8.930 | 8.330 | 9.720 |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 4/14/21 | 4/27/22 | 4/26/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
51.5
CNY
Average target price
62.48
CNY
Spread / Average Target
+21.31%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.30% | 931M | |
| -30.37% | 15.82B | |
| -22.51% | 12.65B | |
| -22.88% | 6.6B | |
| +11.76% | 6.3B | |
| -6.01% | 6.11B | |
| +64.02% | 4.75B | |
| -1.17% | 4.69B | |
| -5.58% | 4.02B | |
| -7.87% | 3.59B |
- Stock Market
- Equities
- 605266 Stock
- Financials Jianzhijia Pharmaceutical Chain Group Co., Ltd.